CERAMCO, INC. – Trademark Portfolio
Entity Type: 03
CERAMCO, INC. holds 49 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 25 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include NEY, SONOMA, VULCAN, CERAMCO, and PALINEY. The owner is based in LONG ISLAND CITY, NY.
31-16 HUNTERS POINT AVE.
LONG ISLAND CITY, NY 11101
Showing of trademarks Trademarks
Trademark Classifications
CERAMCO, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does CERAMCO, INC. have?
CERAMCO, INC. has 49 U.S. trademarks filed with the USPTO. Of these, 10 registered, 8 abandoned, 31 cancelled.
What trademark classes does CERAMCO, INC. file in?
CERAMCO, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 1 (Chemicals), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CERAMCO, INC.'s most well-known trademarks?
CERAMCO, INC.'s registered trademark portfolio includes well-known marks such as NEY, SONOMA, VULCAN, CERAMCO, and PALINEY. These are among 10 currently registered trademarks in the portfolio.
What is CERAMCO, INC.'s trademark registration success rate?
CERAMCO, INC. has a 20% trademark registration rate, with 10 out of 49 resolved applications resulting in successful registration. Currently, 0 applications are pending review.